DCM
XBI icon

Driehaus Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Driehaus Capital Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-450,000
Closed -$1.16M – 450
2022
Q1 		$1.16M Buy
+450,000
New +$41.6M 0.01% 325
2021
Q2 		– Sell
-150,000
Closed -$487K – 533
2021
Q1 		$487K Buy
+150,000
New +$22.5M 0.01% 386
2015
Q4 		– Sell
-80,000
Closed -$960K – 648
2015
Q3 		$960K Sell
80,000
-160,000
-67% -$12.6M 0.03% 357
2015
Q2 		$1.24M Buy
+240,000
New +$18.7M 0.04% 394
2014
Q3 		– Sell
-3,180
Closed -$877K – 626
2014
Q2 		$877K Hold
3,180
– – 0.03% 458
2014
Q1 		$917K Buy
+3,180
New +$163K 0.03% 408

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return